Brands
YSTV
Discover
Events
Newsletter
More

Follow Us

twitterfacebookinstagramyoutube
Yourstory
search

Brands

Resources

Stories

General

In-Depth

Announcement

Reports

News

Funding

Startup Sectors

Women in tech

Sportstech

Agritech

E-Commerce

Education

Lifestyle

Entertainment

Art & Culture

Travel & Leisure

Curtain Raiser

Wine and Food

Videos

ADVERTISEMENT

[Funding alert] Curefit raises $145M from Zomato, others

Tata Digital-backed Curefit is now valued at over $1 billion and has also bought out Fitso from Zomato.

[Funding alert] Curefit raises $145M from Zomato, others

Friday December 03, 2021 , 2 min Read

Fitness platform Curefit Healthcare Pvt Ltd which owns and operates fitness platform Cult.fit has raised $145 million led by food technology Zomato and a group of investors and individuals, according to filings made with the Ministry of Corporate Affairs. 


With the transaction, Zomato has also divested sports facilities platform Fitso to Cure.fit, according to filings made by Zomato with the markets regulator. During its recent quarterly earnings, Zomato said that it will be selling Fitso to Curefit for $50 million, apart from investing an additional $50 million in the company. Zomato had said that it will deploy $1 billion across multiple Indian startups over the next two years.


Zomato had acquired Fitso in January 2021 for an estimated Rs 100 crore or $13.3 million according to current exchange rates.

Mukesh Bansal

Mukesh Bansal, CEO of CureFit Healthcare

Zomato led the round in Curefit with an investment of nearly $100 million, acquiring a 6.38 percent stake in the company. Other investors which participated in the round include San Francisco headquartered South Park Commons Opportunities Fund II, Temasek, and Accel

Senior executives at IIFL Wealth, Paras Sanghvi and Apurva Doshi, also participated in the round apart from Co-founder of Curefit, Mukesh Bansal. Mukesh’s current shareholding in the company stands at 11.23 percent, while co-founder Ankit Nagori holds 0.25 percent. 


With this round, Curefit was valued at nearly $1.5 billion, according to the regulatory documents.


In June, Tata Digital, a subsidiary of Tata Sons, invested $75 million in Curefit, elevating CEO Mukesh Bansal to the role of president at the digital business arm of the conglomerate.


Edited by Kanishk Singh